LAUREN TARTAL: Open Payments
NPI 1619254745 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$492 in 21 payments from 14 companies in 2025. Trend: 2023 $538 · 2024 $579 · 2025 $492
Food & beverage: $492
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $95 |
| Boston Scientific Corporation | 1 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $46 |
| Novartis Pharmaceuticals Corporation | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Alnylam Pharmaceuticals Inc. | 1 | $34 |
| Edwards Lifesciences Corporation | 1 | $33 |
| Novo Nordisk Inc | 1 | $32 |
| Amgen Inc. | 1 | $26 |
| HEARTFLOW, INC. | 1 | $25 |
Products named: Kerendia, WATCHMAN, JARDIANCE, LEQVIO, AMVUTTRA, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), Wegovy, REPATHA.
Industry payments across CO — which companies pay providers there.
